Immunotolerance toward native alphaA-crystallin in knockout mice deficient in the functional protein

• Published in: Immunology letters Vol. 89; no. 2-3; pp. 259 - 265
• Main Authors: Charukamnoetkanok, Puwat, Brady, James P, Wawrousek, Eric F, Egwuagu, Charles E, Zigler, Jr, J Samuel, Vistica, Barbara P, Whitcup, Scott M, Gery, Igal
• Format: Journal Article
• Language: English
• Published: Netherlands 31.10.2003
• Subjects: alpha-Crystallins - deficiency; alpha-Crystallins - genetics; alpha-Crystallins - immunology; Animals; Antibody Formation - immunology; Cattle; Immune Tolerance - immunology; Immunity, Cellular - immunology; Mice; Mice, Knockout; RNA, Messenger - metabolism; Thymus Gland - immunology; Thymus Gland - metabolism
• ISSN: 0165-2478

Immune response against self antigens is normally prevented by an elaborate immunotolerance mechanism. A potential problem for recipients of gene therapy is, therefore, an immune response against the newly introduced gene product. To examine this issue we tested the immune response to the native proteins in knockout (KO) mice in which the genes for alphaA- or alphaB-crystallin were disrupted by partial or complete gene deletion, respectively. alphaA- and alphaB-crystallins are two immunologically distinct polypeptides which form the large ( approximately 800 kDa) complex in the lens referred to as alpha-crystallin. When immunized with murine alpha-crystallin, alphaB-crystallin KO mice, in which the corresponding gene was completely deleted, responded well to the absent self antigen. In contrast, alphaA-crystallin KO mice, with the partial gene deletion, resembled wild type (WT) mice in being immunotolerant toward the native crystallin. Although no functional alphaA-crystallin could be detected in the lens of alphaA-crystallin KO mice, mRNA transcript coding for a truncated alphaA-crystallin gene was found in thymi of these mice, suggesting that thymic expression of a residual fragment of the protein is responsible for the tolerance induction. These data suggest that nonfunctional proteins may induce immunotolerance and protect recipients of gene therapy from immunity against the native proteins.